Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”

Molecular Psychiatry(2024)10.1038/s41380-024-02864-3Source: DataRank Database

Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’” is a research paper published in Molecular Psychiatry (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: closedTopics (18)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (20)

Paulo Alexandre de Oliveira ORCID,Nil Casajuana-Martín ORCID,César Quiroz,Reece C. Budinich,Rana Rais ORCID

Live enrichment

PubMed:39639176 OpenAlex:https://openalex.org/W4405038172

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

Grant: ZIA DA000069

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

Grant: DA049257

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

Grant: ZIA DA000522

Ministry of Economy and Competitiveness | Agencia Estatal de Investigación

Grant: PID2020-113938RB-I00

Ministry of Economy and Competitiveness | Agencia Estatal de Investigación

Grant: Juan de la Cierva fellowship FJC2019-041020-I

Ministry of Economy and Competitiveness | Agencia Estatal de Investigación

Grant: PID2022-140912OB-I00

Generalitat de Catalunya

Grant: 2021-SGR-00230

National Institutes of Health

Grant: 1ZIADA000493-19

Functional and Pharmacological Significance of Receptor Heteromers in the CNS

National Institutes of Health

Grant: 1ZIADA000522-02

Development of Dual Dopamine/Serotonin Releasing Agents

National Institutes of Health

Grant: 5R01DA049257-04

Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement

National Institutes of Health

Grant: 1ZIADA000069-04

Biobehavioral Imaging and Molecular Neuropsychopharmacology of Substance Abuse Mechanisms

closedLicense: Springer Nature TDM

publisherhttps://www.nature.com/articles/s41380-024-02864-3.pdf

publisherhttps://www.nature.com/articles/s41380-024-02864-3

journalhttps://doi.org/10.1038/s41380-024-02864-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39639176

Fields of Study

Treatment of Major DepressionPain Management and Opioid UsePain Mechanisms and Treatments03 medical and health sciences0305 other medical science

Keywords

Abuse liabilityMethadoneOpioidPsychologyPsychiatryLiabilityPharmacologyMedicineReceptorDrugPolitical scienceInternal medicineLaw

Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”

FAIR Checklist

DataRank Breakdown

Authors (20)

Funding (11 grants)

Open Access

Topics